⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Prevention of Chest Pain in Chemo-treated Cancer Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Prevention of Chest Pain in Chemo-treated Cancer Patients

Official Title: Prevention of CArdioToxic-related CHest Pain in Cancer Patients Treated With 5-fluorouracil

Study ID: NCT03486340

Study Description

Brief Summary: This is a prospective, exploratory, randomised clinical trial. Patients with diagnosed cancer that are to be treated with 5-fluorouracil (5-FU) will be randomised into standard oncological treatment or a cardiological assessment prior to the 5-FU treatment. The investigators hypothesize that aggressive management of ischemic risk factors in asymptomatic patients will reduce the number of hospitalisations and investigations for acute coronary syndrome during and after 5-FU treatment and that patients with high coronary artery calcium scores are more likely to experience chest pain during the treatment with 5-FU.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Departments of Oncology and Medicine, Vejle Hospital, Vejle, , Denmark

Contact Details

Name: Vibeke B Hansen, MD, PhD

Affiliation: Vejle Hospital

Role: PRINCIPAL_INVESTIGATOR

Name: Lars H Jensen, MD, PhD

Affiliation: Department of Oncology, Vejle Hospital, Denmark

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: